Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine
- 1 December 2004
- journal article
- Published by Elsevier in Metabolism
- Vol. 53 (12) , 1574-1579
- https://doi.org/10.1016/j.metabol.2004.06.026
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Overweight and obesity in patients with established coronary heart disease: Are we meeting the challenge?Published by Oxford University Press (OUP) ,2004
- Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patientsKidney International, 2002
- Diet and omega-3 fatty acid intervention trial on atherosclerosis. (DOIT-study)Atherosclerosis, 2000
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic HumansJournal of the American College of Cardiology, 1997
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJournal of the American College of Cardiology, 1996
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASEThe Lancet, 1981